Mar 2018 102

Delivery of the Report will take 2-3 working days once order is placed.


An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Scope of the Report:

This report focuses on the Orally Disintegrating Tablet in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Market Segment by Manufacturers, this report covers
- Teva
- Merck
- Mylan
- Pfizer
- Johnson and Johnson
- Otsuka
- Eli Lilly and Company
- AstraZeneca
- Bristol-Myers Squibb
- Conquer

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Other

Market Segment by Applications, can be divided into
- CNS Diseases
- Gastrointestinal Diseases
- CVS Diseases
- Other

There are 15 Chapters to deeply display the global Orally Disintegrating Tablet market.

Chapter 1, to describe Orally Disintegrating Tablet Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Orally Disintegrating Tablet, with sales, revenue, and price of Orally Disintegrating Tablet, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Orally Disintegrating Tablet, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Orally Disintegrating Tablet market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Mar 18)

"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, b...

(Mar 18)

Oligo pools, which are high diversity collections of oligonucleotides, are utilized to generate CRISPR guide RNA (sgRNA) libraries for cloni...

(Mar 18)

Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protoc...

(Mar 18)

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Insti...

(Mar 18)

"This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatos...

(Mar 18)

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of...


Share this report on:

Subscription Option

Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports